During the past decade, Chellaram Diabetes Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chellaram Diabetes Institute" #1 sponsor was "Abbott" with 1 trials, followed by "CymaBay Therapeutics, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Johnson & Johnson Private Limited" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Chellaram Diabetes Institute" are "Type 2 Diabetes Mellitus" (2 trials), "Anemia" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Nephropathies" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Chellaram Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Chellaram Diabetes Institute" are "Drug" (5 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (2 trials), "Placebo" (2 trials), "Actos" (1 trials), "Blood test for Thyroid stimulating hormone (TSH)" (1 trials) and "Canagliflozin + Metformin hydrochloride (Fixed Dose Combination)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chellaram Diabetes Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Chellaram Diabetes Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chellaram Diabetes Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chellaram Diabetes Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".